FDA Adverse Event Malfunction Summary report: N

GYRUS, PK-SP GENERATOR

MDR report key: 9970609 · Received April 16, 2020

Report

Report Number
2951238-2020-00425
Event Type
Malfunction
Date Received
April 16, 2020
Date of Event
March 16, 2020
Report Date
June 24, 2020
Manufacturer
GYRUS ACMI, INC
Product Code
GEI
PMA / PMN Number
K031085
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NC, US
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 0

THIS REPORT IS BEING SUPPLEMENTED TO PROVIDE ADDITIONAL INFORMATION REGARDING THE REPORTED EVENT. ADDITIONAL INFORMATION: H6, H10. CORRECTED DATA: H6 RESULT. A DEFINITIVE ROOT CAUSE COULD NOT BE DETERMINED AS THE REPORTED PHENOMENON COULD NOT BE DUPLICATED. IT WAS NOTED DURING DEVICE EVALUATION THAT THE VENTILATION FAN WAS NOT FUNCTIONING. THIS MAY HAVE CONTRIBUTED TO THE REPORTED PHENOMENON ALLOWING THE RADIO-FREQUENCY (RF) BOARD TO OVERHEAT. FAILURE MAY ALSO BE ATTRIBUTED TO A FAULTY HAND PIECE, FOOT SWITCH OR OTHER ACCESSORY. NONE OF WHICH WERE NOT RETURNED TO OLYMPUS FOR EVALUATION. DEVICE HISTORY RECORD REVIEW INDICATES THAT THE PRODUCT WAS MANUFACTURED AND TESTED IN ACCORDANCE WITH ALL APPLICABLE PROCEDURES AND MET ALL FINAL PRODUCT RELEASE CRITERIA. OLYMPUS WILL CONTINUE TO MONITOR COMPLAINTS FOR THIS DEVICE THROUGH REGULAR TRENDING ACTIVITIES AS DEFINED BY OLYMPUS SURGICAL TECHNOLOGIES AMERICA QUALITY MANAGEMENT SYSTEM PROCEDURE.

Additional Manufacturer Narrative · 1

THE DEVICE WAS RETURNED TO OLYMPUS FOR EVALUATION. THE DEVICE WAS VISUALLY INSPECTED AND THE REPORTED FAILURE MODE COULD NOT BE DUPLICATED.

Description of Event or Problem · 1

IT WAS REPORTED THAT DURING A TRANSURETHRAL RESECTION OF THE PROSTATE (TURP), THERE WAS INTERMITTENT FIRING OF THE DEVICE. THE PROCEDURE WAS COMPLETED USING THE SAME DEVICE. NO PATIENT HARM OCCURRED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
430273 GYRUS, PK-SP GENERATOR ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES GEI GYRUS ACMI, INC 744000

Patients

Seq Age Sex Outcome Treatment
1 78 YR